BioTelemetry Inc. (BEAT) Breaks into New 52-Week High on July 17 Session

Equities Staff |

Shares of BioTelemetry Inc. (BEAT) broke into a new 52-week high yesterday, hitting a peak of $35.40. Shares closed at $34.70 after opening at $34.65 for a move of 0.87%. The company now has a market cap of $994.33 million.

Investors and traders can learn a lot about a stock’s momentum when it sets a new 52-week high. As an example, bullish investors view a company hitting its highest price in a year as a sign of momentum and may interpret it as a signal to buy. On the other hand, bearish investors could view a new 52-week high as a signal of the end of a strong run, with the stock possibly peaking out before an impending period of decline.

For BioTelemetry Inc., the new 52-week high came on volume of 776,078. The stock has a float of 28.66 million shares and average daily volume of $495,845. It has a 50-day SMA of $29.89 and a 200-day SMA of $24.98.

BioTelemetry Inc. now has a P/E ratio of 21.2.

For a complete fundamental analysis analysis of BioTelemetry Inc., check out’s Stock Valuation Analysis report for BEAT.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

BioTelemetry Inc provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Its segments are healthcare, technology and research.

BioTelemetry Inc. is based out of Malvern, PA and has some 1,087 employees. Its CEO is Joseph H. Capper.

BioTelemetry Inc. is also a component of the Russell 2000 Index, which is an invaluable tool for any small-cap investor. Consisting of the smaller 2,000 publicly traded companies of the 3,000 largest companies in America by market cap (which combine to make the broader Russell 3000 index), the Russell 2000 gives the most comprehensive snapshot of the small-cap market of any index out there.

What's more, the Russell 2000 is maintained by Russell Investments, a company committed to using rules-based methodologies to construct unbiased indices that differ from the committee-selected Dow Jones Industrial Average or S&P 500.

To get more information on BioTelemetry Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: BEAT’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

NABUfit Global Inc

NABUfit Global Inc develops online fitness portal and a mobile app with the option of connecting existing and future monitoring devices (wearables etc.).

Private Markets

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…


Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…